{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:57:07Z","timestamp":1794358627480,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":60,"publisher":"Springer New York","isbn-type":[{"value":"9780387775692","type":"print"},{"value":"9780387775708","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-0-387-77570-8_1","type":"book-chapter","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T15:35:16Z","timestamp":1221233716000},"page":"1-8","source":"Crossref","is-referenced-by-count":6,"title":["Arsenite Resistance in Leishmania and Possible Drug Targets"],"prefix":"10.1007","author":[{"given":"Gaganmeet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. G.","family":"Jayanarayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmoy S.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1179\/000349803225002570","volume":"97","author":"R. Russo","year":"2003","unstructured":"Russo R, Laguna F, Lopez-Velez R et al. Visceral leishmaniasis in those infected with HIV: Clinical aspects and other opportunistic infections. Ann Trop Med Parasitol 2003; 97:99\u2013105.","journal-title":"Ann Trop Med Parasitol"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","volume":"19","author":"S.L. Croft","year":"2003","unstructured":"Croft SL, Coombs GH. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003; 19:502\u2013508.","journal-title":"Trends Parasitol"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","volume":"6","author":"S.L. Croft","year":"2001","unstructured":"Croft SL. Monitoring drug resistance in leishmaniasis. Trop Med Int Health 2001; 6:899\u2013905.","journal-title":"Trop Med Int Health"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","volume":"7","author":"M. Oullette","year":"2004","unstructured":"Oullette M, Drummelsmith J, Papadopoulou B. Leishmaniasis: Drugs in clinic, resistance and new developments. Drug Resist Updat 2004; 7:257\u201366.","journal-title":"Drug Resist Updat"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-9292-2-14","volume":"2","author":"A. Ponte-Sucre","year":"2003","unstructured":"Ponte-Sucre A. Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy. Kinetoplastid Biol Dis 2003; 2:14.","journal-title":"Kinetoplastid Biol Dis"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0014-4827(89)90220-6","volume":"180","author":"S. Detke","year":"1989","unstructured":"Detke S, Katakura K, Chang KP. DNA amplification in arsenite resistant Leishmania. Exp Cell Res 1989; 180:161\u2013170.","journal-title":"Exp Cell Res"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/j.1460-2075.1991.tb08035.x","volume":"10","author":"M. Ouellette","year":"1991","unstructured":"Ouellette M, Hettema E, Wust D et al. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania. EMBO J 1991; 10:1009\u20131016.","journal-title":"EMBO J"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"18427","DOI":"10.1016\/S0021-9258(18)55077-8","volume":"266","author":"H.L. Callahan","year":"1991","unstructured":"Callahan HL, Beverley SM. Heavy metal resistance: A new role for P-glycoproteins in Leishmania. J Biol Chem 1991; 266:18427\u201330.","journal-title":"J Biol Chem"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0166-6851(92)90169-K","volume":"56","author":"L. Sho-Tone","year":"1992","unstructured":"Sho-Tone L, Tarn C, Wang CY. Characterization of sequence changes in kinetoplast DNA maxicircles of drug-resistant Leishmania. Mol Biochem Parasitol 1992; 56:197\u2013208.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/PL00008548","volume":"86","author":"V. Prasad","year":"2000","unstructured":"Prasad V, Kaur J, Dey CS. Arsenite-resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment. Parasitol Res 2000; 86:661\u2013664.","journal-title":"Parasitol Res"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev.mi.45.100191.002221","volume":"45","author":"S.M. Beverley","year":"1991","unstructured":"Beverley SM. Gene amplification in Leishmania. Annu Rev Microbiol 1991; 45:417\u201344.","journal-title":"Annu Rev Microbiol"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0923-2508(91)90089-S","volume":"142","author":"M. Ouellette","year":"1991","unstructured":"Ouellette M, Borst P. Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania. Res Microbiol 1991; 142:737\u2013746.","journal-title":"Res Microbiol"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/00034983.1994.11812849","volume":"88","author":"M. Segovia","year":"1994","unstructured":"Segovia M. Leishmania gene amplification: A mechanism of drug resistance. Ann Trop Med Parasitol 1994; 88:123\u201330.","journal-title":"Ann Trop Med Parasitol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1046\/j.1365-3156.2002.00911.x","volume":"7","author":"H.D. Schallig","year":"2002","unstructured":"Schallig HD, Oskam L. Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification. Trop Med Int Health 2002; 7:641\u201351.","journal-title":"Trop Med Int Health"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0169-4758(93)90135-3","volume":"9","author":"M. Ouellette","year":"1993","unstructured":"Ouellette M, Papadopoulou B. Mechanism of drug resistance in Leishmania. Parasitol Today 1993; 9:150\u2013153.","journal-title":"Parasitol Today"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/nar\/21.8.1895","volume":"21","author":"K. Grondin","year":"1993","unstructured":"Grondin K, Papadopoulou B, Ouellette M. Homologous recombination between direct repeats sequences yields P-glycoprotein containing circular amplicons in arsenite resistant Leishmania. Nucleic Acids Res 1993; 21:1895\u20131901.","journal-title":"Nucleic Acids Res"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/S0021-9258(18)69087-8","volume":"263","author":"S. Detke","year":"1988","unstructured":"Detke S, Chaudhuri G, Kink JA et al. DNA amplification in tunicamycin-resistant Leishmania mexicana. Multicopies of a single 63-kilobase supercoiled molecule and their expression. J Biol Chem 1988; 263:3418\u20133424.","journal-title":"J Biol Chem"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0092-8674(84)90498-7","volume":"38","author":"S.M. Beverley","year":"1984","unstructured":"Beverley SM, Coderre JA, Santi DV et al. Unstable DNA amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization. Cell 1984; 38:431\u2013439.","journal-title":"Cell"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/j.1460-2075.1990.tb08206.x","volume":"9","author":"M. Ouellette","year":"1990","unstructured":"Ouellette M, Fase-Fowler F, Borst P. The amplified H circle of methotrexate resistant Leishmania contains a novel P-glycoprotein gene. EMBO J 1990; 9:1027\u20131033.","journal-title":"EMBO J"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"18427","DOI":"10.1016\/S0021-9258(18)55077-8","volume":"266","author":"H.L. Callahan","year":"1991","unstructured":"Callahan HL, Beverley SM. Heavy metal resistance: A new role for P-glycoproteins in Leishmania. J Biol Chem 1991; 266:18427\u201330.","journal-title":"J Biol Chem"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"11980","DOI":"10.1016\/S0021-9258(17)32670-4","volume":"269","author":"B. Papadopoulou","year":"1994","unstructured":"Papadopoulou B, Roy G, Dey S et al. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J Biol Chem 1994; 269:11980\u20136.","journal-title":"J Biol Chem"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0166-6851(94)90095-7","volume":"67","author":"S. Dey","year":"1994","unstructured":"Dey S, Papadopoulou B, Haimeur A et al. High level resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol Biochem Parasitol 1994; 67:49\u201357.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/emboj\/16.11.3057","volume":"6","author":"K. Grondin","year":"1997","unstructured":"Grondin K, Haimeur A, Mukhopadhyay R et al. Coamplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 1997; 6:3057\u20133065.","journal-title":"EMBO J"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0166-6851(94)90049-3","volume":"66","author":"A.K. Singh","year":"1994","unstructured":"Singh AK, Liu HY, Lee ST. Atomic absorption spectrophotometric measurement of intracellular arsenite in arsenite-resistant Leishmania. Mol Biochem Parasitol 1994; 66:161\u2013164.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1006\/bbrc.1996.1098","volume":"224","author":"B. Papadopoulou","year":"1996","unstructured":"Papadopoulou B, Roy G, Dey S et al. Gene disruption of the P-glycoprotein related gene pgpa of Leishmania tarentolae. Biochem Biophys Res Commun 1996; 224:772\u2013778.","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.93.5.2192","volume":"93","author":"S. Dey","year":"1996","unstructured":"Dey S, Ouellette M, Lightbody J et al. An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc Natl Acad Sci USA 1996; 93:2192\u20132197.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1073\/pnas.93.19.10383","volume":"93","author":"R. Mukhopadhyay","year":"1996","unstructured":"Mukhopadhyay R, Dey S, Xu N et al. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc Natl Acad Sci USA 1996; 93:10383\u201310387.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1006\/bbrc.2000.2680","volume":"271","author":"J. Kaur","year":"2000","unstructured":"Kaur J, Dey CS. Putative P-glycoprotein expression in arsenite-resistant Leishmania donovani down-regulated by verapamil. Biochem Biophys Res Commun 2000; 271:615\u2013619.","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molbiopara.2005.03.009","volume":"142","author":"Y.C. Lin","year":"2005","unstructured":"Lin YC, Hsu JY, Chiang SC et al. Distinct overexpression of cytosolic and mitochondrial tryparedoxin peroxidases results in preferential detoxification of different oxidants in arsenite-resistant Leishmania amazonensis with and without DNA amplification. Mol Biochem Parasitol 2005; 142:66\u201375.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2710.2002.00431.x","volume":"27","author":"K.G. Jayanarayan","year":"2002","unstructured":"Jayanarayan KG, Dey CS. Microtubules: Dynamics, drug interaction and drug resistance in Leishmania. J Clin Pharm Therapeut 2002; 27:313\u2013320.","journal-title":"J Clin Pharm Therapeut"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0166-6851(98)00146-7","volume":"98","author":"K.A. Werbovetz","year":"1999","unstructured":"Werbovetz KA, Brendle JJ, Sackett DL. Purification, characterization, and drug susceptibility of tubulin from Leishmania. Mol Biochem Parasitol 1999; 98:53\u201365.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0165-6147(88)90258-1","volume":"9","author":"S.L. Croft","year":"1988","unstructured":"Croft SL. Recent developments in the chemotherapy of leishmaniasis. Trends Pharmacol Sci 1988; 9:376\u2013381.","journal-title":"Trends Pharmacol Sci"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0169-4758(90)90069-G","volume":"6","author":"T. Seeback","year":"1990","unstructured":"Seeback T, Hemphill A, Lawson D. The Cytoskeleton of trypanosomes. Parasitol Today 1990; 6:49\u201352.","journal-title":"Parasitol Today"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/PL00008510","volume":"86","author":"V. Prasad","year":"2000","unstructured":"Prasad V, Kumar SS, Dey CS. Resistance to arsenite modulates levels of alpha-tubulin and sensitivity to paclitaxel in Leishmania donovani. Parasitol Res 2000; 86:838\u2013842.","journal-title":"Parasitol Res"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s004360000249","volume":"86","author":"V. Prasad","year":"2000","unstructured":"Prasad V, Dey CS. Tubulin is hyperphosphorylated on serine and tyrosine residues in arsenite-resistant Leishmania donovani promastigotes. Parasitol Res 2000; 86:876\u2013880.","journal-title":"Parasitol Res"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s00436-002-0632-5","volume":"88","author":"K.G. Jayanarayan","year":"2002","unstructured":"Jayanarayan KG, Dey CS. Resistance to arsenite modulates expression of beta-and gamma-tubulin and sensitivity to paclitaxel during differentiation of Leishmania donovani. Parasitol Res 2002; 88:754\u2013759.","journal-title":"Parasitol Res"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ijpara.2004.03.009","volume":"34","author":"K.G. Jayanarayan","year":"2004","unstructured":"Jayanarayan KG, Dey CS. Altered expression, polymerisation and cellular distribution of alpha-\/beta-tubulins and apoptosis-like cell death in arsenite resistant Leishmania donovani promastigotes. Int J Parasitol 2004; 34:915\u2013925.","journal-title":"Int J Parasitol"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/13543784.9.4.779","volume":"9","author":"C. Dumontet","year":"2000","unstructured":"Dumontet C. Mechanism of action and resistance to tubulin binding agents. Expert Opinion Inves Drugs 2000; 9:779\u2013788.","journal-title":"Expert Opinion Inves Drugs"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1073\/pnas.96.1.115","volume":"96","author":"V. Rodionov","year":"1999","unstructured":"Rodionov V, Nadezhdina E, Boriy G. Centrosomal control of microtubule dynamics. Proc Natl Acad Sci USA 1999; 96:115\u2013120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/(SICI)1521-1878(199810)20:10<830::AID-BIES8>3.0.CO;2-N","volume":"20","author":"R.L. Margolis","year":"1998","unstructured":"Margolis RL, Wilson L. Microtubule treadmilling: What goes around comes around. Bioessays 1998; 20:830\u2013836.","journal-title":"Bioessays"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0305-0491(88)90320-3","volume":"90","author":"M. Little","year":"1988","unstructured":"Little M, Seehaus T. Comparative analyses of tubulin sequences. Comp Biochem Physiol 1988; 90:655\u2013670.","journal-title":"Comp Biochem Physiol"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/jm00020a001","volume":"38","author":"I. Ojima","year":"1995","unstructured":"Ojima I. A new paclitaxel photoaffinity analog with a 3-(4-benzoylphenyl)propanoyl probe for characterization of drug-binding sites on tubulin and P-glycoprotein. J Med Chem 1995; 38:3891\u20133894.","journal-title":"J Med Chem"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S0031182005007687","volume":"131","author":"K.G. Jayanarayan","year":"2005","unstructured":"Jayanarayan KG, Dey CS. Altered tubulin dynamics, localization and post-translational modifications in sodium arsenite resistant Leishmania donovani in response to paclitaxel, trifluralin and a combination of both and induction of apoptosis-like cell death. Parasitology 2005; 131:215\u2013230.","journal-title":"Parasitology"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/1389557023405648","volume":"2","author":"K.A. Werbovetz","year":"2002","unstructured":"Werbovetz KA. Tubulin as an antiprotozoal drug target. Mini Rev Med Chem 2002; 2:519\u2013529.","journal-title":"Mini Rev Med Chem"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0166-6851(00)00272-3","volume":"110","author":"C.G. Havens","year":"2000","unstructured":"Havens CG, Bryant N, Asher L et al. Cellular effects of leishmanial tubulin inhibitors on Leishmania donovani. Mol Biochem Parasitol 2000; 110:223\u201336.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrm831","volume":"3","author":"J.C. Wang","year":"2002","unstructured":"Wang JC. Cellular roles of DNA topoisomerases: A molecular prospective. Nat Rev Mol Cell Biol 2002; 3:430\u2013440.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1054-3589(08)60342-7","volume":"21","author":"E. Schneider","year":"1991","unstructured":"Schneider E, Hsiang YH, Liu LF. DNA topoisomerases as antitumor drug targets. Adv Pharmacol 1991; 21:149\u2013183.","journal-title":"Adv Pharmacol"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2001-10635","volume":"67","author":"P. Heisig","year":"2001","unstructured":"Heisig P. Inhibitors of bacterial topoisomerases: Mechanisms of action and resistance and clinical aspects. Planta Med 2001; 67:3\u201312.","journal-title":"Planta Med"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/1566524043360096","volume":"4","author":"J. Shlomai","year":"2004","unstructured":"Shlomai J. The structure and replication of kinetoplast DNA. Curr Mol Med 2004; 4:623\u2013647.","journal-title":"Curr Mol Med"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0166-6851(92)90169-K","volume":"56","author":"S.T. Lee","year":"1992","unstructured":"Lee ST, Tarn C, Wang CY. Characterization of sequence changes in kinetoplast DNA maxicircles of drug-resistant Leishmania. Mol Biochem Parasitol 1992; 56:197\u2013207.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0166-6851(93)90041-U","volume":"58","author":"S.T. Lee","year":"1993","unstructured":"Lee ST, Tarn C, Chang KP. Characterization of the switch of kinetoplast DNA minicircle dominance during development and reversion of drug resistance in Leishmania. Mol Biochem Parasitol 1993; 58:187\u2013203.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/MCB.14.1.587","volume":"14","author":"S.T. Lee","year":"1994","unstructured":"Lee ST, Liu HY, Lee SP et al. Selection for arsenite resistance causes reversible changes in minicircle composition and kinetoplast organization in Leishmania mexicana. Mol Cell Biol 1994; 14:587\u2013596.","journal-title":"Mol Cell Biol"},{"key":"1_CR53","first-page":"2569","volume":"20","author":"Q.Q. Pu","year":"2000","unstructured":"Pu QQ, Bezwoda WR. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line. Anticancer Res 2000; 20:2569\u201322578.","journal-title":"Anticancer Res"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1078\/0944-5013-00177","volume":"158","author":"K.G. Jayanarayan","year":"2003","unstructured":"Jayanarayan KG, Dey CS. Overexpression and increased DNA topoisomerase II-like enzyme activity in arsenite resistant Leishmania donovani. Microbiol Res 2003; 158:55\u201358.","journal-title":"Microbiol Res"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbiopara.2005.01.014","volume":"141","author":"G. Singh","year":"2005","unstructured":"Singh G, Jayanarayan KG, Dey CS. Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani. Mol Biochem Parasitol 2005; 141:57\u201369.","journal-title":"Mol Biochem Parasitol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.mi.49.100195.001001","volume":"49","author":"T.A. Shapiro","year":"1995","unstructured":"Shapiro TA, Englund PT. The structure and replication of kinetoplast DNA. Annu Rev Microbiol 1995; 49:117\u2013143.","journal-title":"Annu Rev Microbiol"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","volume":"99","author":"A.K. Larsen","year":"2003","unstructured":"Larsen AK, Escargueil AE, Skladanowski A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther 2003; 99:167\u2013181.","journal-title":"Pharmacol Ther"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","volume":"48","author":"N.K. Verma","year":"2004","unstructured":"Verma NK, Dey CS. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 2004; 48:3010\u20133015.","journal-title":"Antimicrob Agents Chemother"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1093\/nar\/gkg806","volume":"31","author":"C. Guimond","year":"2003","unstructured":"Guimond C, Trudel N, Brochu C et al. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res 2003; 31:5886\u20135896.","journal-title":"Nucleic Acids Res"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1074\/mcp.M200085-MCP200","volume":"2","author":"J. Drummelsmith","year":"2003","unstructured":"Drummelsmith J, Brochu V, Girard I et al. Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol Cell Proteomics 2003; 2:146\u2013155.","journal-title":"Mol Cell Proteomics"}],"container-title":["Advances In Experimental Medicine And Biology","Drug Targets in Kinetoplastid Parasites"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-387-77570-8_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:16:34Z","timestamp":1631776594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-0-387-77570-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9780387775692","9780387775708"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-0-387-77570-8_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-0-387-77570-8","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[]}}